Hôpital de la Timone-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3